125 related articles for article (PubMed ID: 22559807)
1. [Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature].
Adam Z; Szturz P; Bučková P; Cervinková I; Koukalová R; Rehák Z; Krejčí M; Pour L; Zahradová L; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Apr; 58(4):313-8. PubMed ID: 22559807
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
[TBL] [Abstract][Full Text] [Related]
3. [Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease].
Adam Z; Balsíková K; Pour L; Krejcí M; Svacina P; Dufek M; Kren L; Hermanová M; Moulis M; Vanícek J; Neubauer J; Mechl M; Prásek J; Stanícek J; Koukalová R; Hájek R; Mayer J
Vnitr Lek; 2009 Dec; 55(12):1173-88. PubMed ID: 20070034
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoids.
Darstein F; Kirschey S; Heckl S; Rahman F; Schwarting A; Schuchmann M; Galle PR; Zimmermann T
Intern Med J; 2014 Jan; 44(1):90-2. PubMed ID: 24450524
[TBL] [Abstract][Full Text] [Related]
5. Anakinra-responsive lichen planus in a woman with Erdheim-Chester disease: a therapeutic enigma.
Cohen PR; Kurzrock R
Dermatol Online J; 2014 Jan; 20(1):21241. PubMed ID: 24456945
[TBL] [Abstract][Full Text] [Related]
6. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
7. A case of Erdheim-Chester disease initially mistaken for Ormond's disease.
Loddenkemper K; Hoyer B; Loddenkemper C; Hermann KG; Rogalla P; Förster G; Buttgereit F; Hiepe F; Burmester GR
Nat Clin Pract Rheumatol; 2008 Jan; 4(1):50-5. PubMed ID: 18172449
[TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester disease with cardiac involvement successfully treated with anakinra.
Killu AM; Liang JJ; Jaffe AS
Int J Cardiol; 2013 Sep; 167(5):e115-7. PubMed ID: 23659884
[No Abstract] [Full Text] [Related]
9. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
[TBL] [Abstract][Full Text] [Related]
10. [Erdheim-chester disease: a rare cause of interstitial lung disease].
Krüger S; Krop C; Wibmer T; Pauls S; Mottaghy FM; Schumann C; Hombach V
Med Klin (Munich); 2006 Jul; 101(7):573-6. PubMed ID: 16850173
[TBL] [Abstract][Full Text] [Related]
11. [Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
Adam Z; Sprláková A; Rehák Z; Koukalová R; Szturz P; Krejcí M; Pour L; Zahradová L; Cervinek L; Kren L; Moulis M; Hermanová M; Mechl M; Prásek J; Hájek R; Král Z; Mayer J
Klin Onkol; 2011; 24(5):367-81. PubMed ID: 22070019
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent pericardial effusion as first manifestation of Erdheim-Chester disease].
Lutz SZ; Schmalzing M; Vogel-Claussen J; Adam P; May AE
Dtsch Med Wochenschr; 2011 Sep; 136(39):1952-6. PubMed ID: 21935854
[TBL] [Abstract][Full Text] [Related]
13. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
Front Immunol; 2018; 9():1233. PubMed ID: 29910817
[TBL] [Abstract][Full Text] [Related]
14. Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients.
Haroche J; Amoura Z; Trad SG; Wechsler B; Cluzel P; Grenier PA; Piette JC
Arthritis Rheum; 2006 Oct; 54(10):3330-6. PubMed ID: 17009306
[TBL] [Abstract][Full Text] [Related]
15. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal infiltration as the first sign of Erdheim-Chester disease.
Colin P; Ballereau C; Lambert M; Lemaitre L; Leroy X; Biserte J
Int J Urol; 2008 May; 15(5):455-6. PubMed ID: 18452465
[TBL] [Abstract][Full Text] [Related]
17. Impact of anakinra treatment on cytokine and lymphocytes/ monocytes profile of an Erdheim-Chester patient.
Sevčíková S; Kubiczková L; Sedlaříková L; Ríhová L; Kryukov F; Szturz P; Hajek R; Pour L; Adam Z
Klin Onkol; 2014; 27(4):276-82. PubMed ID: 25115717
[TBL] [Abstract][Full Text] [Related]
18. [Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease].
Adam Z; Krejcí M; Pour L; Neubauer J; Prásek J; Hájek R
Vnitr Lek; 2008 Dec; 54(12):1140-53. PubMed ID: 19140523
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein.
Courcoul A; Vignot E; Chapurlat R
Joint Bone Spine; 2014 Mar; 81(2):175-7. PubMed ID: 23953221
[TBL] [Abstract][Full Text] [Related]
20. Compression of kidneys in Erdheim-Chester disease of retroperitoneum: Open surgical approach.
Wimpissinger TF; Schernthaner G; Feichtinger H; Stackl W
Urology; 2005 Apr; 65(4):798. PubMed ID: 15833540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
